Updated hourlyHourly refreshSun, Oct 25, 2026
Industrial · Biotech & pharma
The Biopharmaceutical Fermentation Market is gaining importance as pharmaceutical and biotechnology companies increasingly adopt advanced manufacturing technologies to develop biologics, vaccines, therapeutic proteins, enzymes, and other biotechnology-derived products. Fermentation processes utilize microorganisms, including bacteria, yeast, and other engineered biological systems, ...
Read more
Oct 23 · 10:34·PR News Releaser
Biotech & pharma
82% objective response rate, median progression-free survival (PFS) not yet reached, and 9-month PFS-rate of 88% in patients with 2L/3L pancreatic cancer treated with vopimetostat plus daraxonrasib
Oct 23 · 10:30·GlobeNewswire
Biotech & pharma
According to The Insight Partners The EXTL1 Antibody Market size is projected to grow from US$ 1.33 billion in 2025 to US$ 2.56 billion by 2034, registering a CAGR of 8.50% during 2026–2034. The global EXTL1 Antibody Market is experiencing ...
Read more
Oct 23 · 10:23·PR News Releaser
Finance · Healthcare
Merck Foundation (www.Merck-Foundation.com), the philanthropic arm of Merck KGaA Germany, launched their Educating Linda Program to support girl education at Kenya State House, in partnership with H.E. Mrs. RACHEL RUTO E.G.H, The First Lady of the Republic of Kenya and Ambassador of “Merck Foundation More Than a Mother”. During the visit, the Merck Foundation Kenya Alumni Summit 2026 was also conducted to highlight the impact of their scholarships program with the aim to build healthcare capacity and transform patient care landscape across Kenya nationwide.
The program was attended by The First Lady of the Republic of Kenya H.E. Mrs. RACHEL RUTO E.G.H, Chairman of Merck Foundation Board of Trustees, Prof. Dr. Frank Stangenberg-Haverkamp, and CEO of Merck Foundation and President of “More Than a Mother” Campaign, Dr. Rasha Kelej and Kenya Minister of Health, Hon. Aden Duale.
Senator Dr. Rasha Kelej (Ret.), CEO of Merck Foundation and President of “More Than a Mother” Campaign emphasized, “It is a great pleasure to meet my dear sister, H.E. Mrs. RACHEL RUTO E.G.H. First Lady of the Republic of Kenya and to recognize her for her tremendous efforts as the Ambassador of “Merck Foundation More Than a Mother”.
I am proud that through our long-term partnership we have provided 328 scholarships for young Kenyan healthcare providers in 44 critical and underserved specialties. I am also happy to share that nearly 50% of these scholarships have been awarded to women healthcare providers, reinforcing our commitment to women empowerment.
It was also great meeting Kenya Minister of Health, Hon. Aden Duale and our Alumni, who are the future healthcare experts of Kenya.”
“We are looking forward to extending our scholarship program to more healthcare providers in partnership with First Lady of Kenya and in collaboration with Medical Societies and Ministry of Health when possible.” She added.
H.E. Mrs. Rachel Ruto E.G.H., The First Lady of the Republic of Kenya expressed,
“Through our impactful partnership with Merck Foundation, we are not just implementing programs, we are transforming lives. Together, we are strengthening our healthcare capacity, empowering girls through education, breaking infertility stigma, and addressing other critical social and health challenges across Kenya. We are immensely proud that, through our strong partnership, we have been able to provide 328 scholarships for our healthcare providers, not only in the capital city, but across the country. It represents a powerful investment in the future of our healthcare system, a commitment to building expertise where it is needed most, and a significant step towards ensuring equitable access to quality care for all our people.
At the same time, we are equally proud to support the education of 47 high-performing yet underprivileged Kenyan schoolgirls, providing them with annual scholarships till they graduate. By empowering these young girls through education, we are not only transforming individual lives, but also shaping stronger families, communities, and a brighter future for our nation.”
Prof. Dr. Frank Stangenberg-Haverkamp Chairman of Merck Foundation Board of Trustees added, “Our aim is to improve the overall health and wellbeing of people by building healthcare capacity in Kenya and across developing countries. We are strongly committed to transforming patient care through our scholarships program.”
Hon. Aden Duale, Cabinet Secretary, Ministry of Health, Kenya shared, “We sincerely appreciate the Merck Foundation Scholarships Program through which 328 scholarships have been provided till today for our local healthcare providers in many critical underserved specialties, helping us to build and strengthen our healthcare capacity, across the country.”
One of the important specialties that Merck Foundation is focusing on in 2025 and 2026 in Kenya is the scholarship of One Year Diploma in Nutrition, to support the program of Feeding and Food Security of Kenya First Lady.
More than 90 scholarships are dedicated to this specialty across the 47 provinces of Kenya. This will create a culture shift in leading a healthy lifestyle for the whole population which will contribute to healthier communities and hence social and economic development of the whole country nationwide.
The program was also attended by the Kenyan winners of Merck Foundation Media Awards 2024 and 2025.
“It was a pleasure meeting and celebrating our Winners, the health and social champions, who are the voice of the voiceless”, added Dr. Rasha Kelej.
Out of the total 328 scholarships, Merck Foundation has provided:
121 scholarships for one-year postgraduate diplomas and two-year master’s degrees in Diabetes, Preventative Cardiovascular Medicine, Cardiology, and Endocrinology. These programs enable doctors to establish specialized diabetes clinics across the country.
10 scholarships for Oncology, which is a critical specialty to strengthen cancer care capacity.
49 scholarships for Fertility, Embryology, and Reproductive Medicine under the “More Than a Mother” campaign, bringing hope and support to couples facing infertility challenges.
148 scholarships for other important specialties such as Internal Medicine, Psychiatry, Neurology, Emergency Medicine, Dermatology, and many more, contributing significantly to strengthening Kenya’s healthcare system.
Merck Foundation has overall provided more than 2,600 scholarships for healthcare providers in 44 critical and undeserved specialties from over 52 countries.
During the Summit, Merck Foundation alumni shared inspiring testimonies on how these scholarships have transformed their professional journeys and improved patient care in their communities.
Merck Foundation, in partnership with the First Lady of Kenya, is also launching children’s storybooks — “More Than a Mother”, “Educating Linda”, “Jackline’s Rescue”, “Not Who You Are”, “Ride into the Future”, “Sugar Free Jude” and “Mark’s Pressure” in English and Swahili to raise awareness about critical social and health issues among young children. Thousands of copies will be distributed across schools in Kenya. These storybooks have also been adapted into animated films to further enhance their impact.
Moreover, Merck Foundation has conducted 4 Editions of their Online Health Media Training for Kenyan journalists to empower them to raise awareness about sensitive social and health issues such as breaking infertility stigma, supporting girl education, ending child marriage and GBV, and promoting healthy lifestyle practices.
Merck Foundation, together with the First Lady of Kenya, also organizes annual awards for media, musicians, filmmakers, and fashion designers to encourage creative talents to raise awareness about important social issues.
Merck Foundation in partnership with the First Lady of the Republic of Kenya has also announced the Call for Application for their important annual Awards for Media, Musicians, Fashion Designers, Filmmakers, students, and new potential talents in these fields.
Details of the Awards:
1. Merck Foundation Media Recognition Awards 2026 “Diabetes & Hypertension”: Media representatives are invited to showcase their work through strong and influential messages to promote a healthy lifestyle and raise awareness about the prevention and early detection of Diabetes and Hypertension.
Submission deadline: 30th October 2026.
2. Merck Foundation Film Awards 2026 “Diabetes & Hypertension”: All Filmmakers, Students of Film Making Training Institutions, or Young Talents are invited to create and share a long or short FILMS, either drama, documentary, or docudrama to deliver strong and influential messages to promote a healthy lifestyle raise awareness about prevention and early detection of Diabetes and Hypertension.
Submission deadline: 30th October 2026.
3. Merck Foundation Fashion Awards 2026 “Diabetes & Hypertension”: All Students and Designers are invited to create and share designs to deliver strong and influential messages to promote a healthy lifestyle and raise awareness about the prevention and early detection of Diabetes and Hypertension.
Submission deadline: 30th October 2026.
4. Merck Foundation Song Awards 2025 “Diabetes & Hypertension”: All Singers and Musical Artists are invited to create and share a SONG with the aim to promote a healthy lifestyle and raise awareness about the prevention and early detection of Diabetes and Hypertension.
Submission deadline: 30th October 2026.
Apply here: https://apo-opa.co/4siT2b4
Entries for all the awards are to be submitted via email to:
submit@merck-foundation.com
Distributed by APO Group on behalf of Merck Foundation.
Contact:
mehak.handa@external.merckgroup.com
Join the conversation on our social media platforms below and let your voice be heard!
https://apo-opa.co/4siApEp
https://apo-opa.co/4sjDsw3
https://apo-opa.co/48grr0V
https://apo-opa.co/4k9Cq3t
https://apo-opa.co/4stVHij
https://apo-opa.co/4i0xWef
www.Merck-Foundation.com
https://apo-opa.co/4yD9HHU
About Merck Foundation:
Merck Foundation works across more than 50 countries with First Ladies, their Foundations, Ministries, and other key stakeholders. Through complementary roles in advocacy, local government coordination, healthcare & media capacity building, girls’ education, and community awareness initiatives.
It is this coordinated ecosystem of partnerships—with distinct responsibilities and a shared vision—that enables Merck Foundation to build local capacity, create sustainable impact, and contribute to long-term transformation in healthcare and society.
Through their various programs and initiatives, Merck Foundation has provided 2,750+ scholarships for healthcare providers from 52 countries in 44 critical and underserved specialties, awarded 1,570+ scholarships to underprivileged African schoolgirls across 21 countries, trained 4,000+ media professionals, recognized 980 award winners, and reached 9+ million followers across 15 social media channels, driving lasting impact in healthcare, education, and awareness across Africa and Asia.
The Merck Foundation is dedicated to improving social and health outcomes for communities in need. While it collaborates with various partners, including governments to achieve its humanitarian goals, the foundation remains strictly neutral in political matters. It does not engage in or support any political activities, elections, or regimes, focusing solely on its mission to elevate humanity and enhance well-being while maintaining a strict non-political stance in all of its endeavors.
All Merck Foundation press releases are distributed by e-mail at the same time they become available on the Merck Foundation Website. Please visit www.Merck-Foundation.com to read more. Follow the social media of Merck Foundation: Facebook (https://apo-opa.co/4siApEp), X (https://apo-opa.co/4sjDsw3),Instagram (https://apo-opa.co/4k9Cq3t), YouTube (https://apo-opa.co/48grr0V), Threads (https://apo-opa.co/4stVHij) and Flickr (https://apo-opa.co/4i0xWef).
This content is not intended for US/ Canadian audiences.
Oct 23 · 10:22·APO Group
Biotech & pharma
Zymeworks to receive a $55 million upfront payment and a $40 million payment upon initiation of the Phase 1b trial, with potential for up to $718 million in additional development, commercial and sales-based milestones Zymeworks also eligible to receive tiered high-single-digit to mid-teen royalties on global net sales protected by patents extending into 2040’s Zymeworks … Continue reading "Zymeworks Enters into an Exclusive Global License and Collaboration Agreement with Roche for ZW209, a Trispecific T cell Engager Targeting DLL3"
Oct 23 · 10:15·PressReach
Biotech & pharma
Registrational Phase 3 G-HOPE-001 Study Met Both Primary Endpoints, Demonstrating Statistically Significant and Clinically Meaningful Overall Survival and Progression-Free Survival Benefits in Previously Treated, CLDN18.2-positive Gastric Cancer Arcotatug Tavatecan Demonstrated a...
Oct 23 · 10:09·PR Newswire
Healthcare · Biotech & pharma
YICHANG, China, Oct. 23, 2026 -- Angel Yeast (SSE: 600298), one of the world's leading yeast manufacturers, has hosted the 2026 International Synthetic Biology Symposium and the Angel Group High-Quality Development Conference in Yichang, its headquarters city, on October...
Oct 23 · 10:01·PR Newswire
Healthcare · Energy
RCT's focused-energy approach delivers therapeutic results in 3-5 sessions, now available at the Center for New Medicine in Irvine, California IRVINE, CA, UNITED STATES, October 23, 2026 / EINPresswire.com / -- ReGen Medical Network Teams with Center for New Medicine to Bring Advanced Regenerative Technology to Leading Integrative Medicine Practice Strategic Alliance Expands Access to Cutting-Edge Cellular and Aesthe
Oct 23 · 10:00·EIN Presswire
Biotech & pharma
17.4-month median OS in 2L SCLC (n=51) and 14.7-month median OS in 2L + ≥3L SCLC (n=101) 72.5% (37/51) ORR and 60.8% (31/51) cORR in 2L SCLC with 6.9-month median PFS; 68.3% (69/101) ORR and 54.5% (55/101) cORR in 2L + ≥3L SCLC with 6.8-month median PFS 76.9% (20/26) ORR and 65.4% (17/26)...
Oct 23 · 10:00·PR Newswire
Finance · SaaS
The MONUSCO Police (UNPOL) supported a forum held in Kinshasa on Wednesday, 21 October, organized by the Congolese National Police (PNC) in collaboration with the U-Report platform. The forum focused on youth, peace, health and community safety.
Participants included young people, health-sector stakeholders, civil society representatives and residents of Mont-Ngafula, where the local U-Report section initiated the event. The initiative aims to draw public attention to drug use and violence among young people.
According to the mayor of Mont-Ngafula, the municipality is particularly affected by the use of psychoactive substances among young people, a practice that often leads to violence.
“Our young people face many challenges, particularly drug use,” said Séverin Lumbu.
Andréa Amisi, who coordinates U-Report in the municipality, shares the mayor’s concerns. His youth and involvement in U-Report bring him into contact with many young people. He regrets that, in the absence of opportunities and proper guidance, many young people turn to hard liquor and psychoactive substances.
He also points out that most of those selling these products are young people themselves. This trade provides them with a source of income while endangering the health of other young people and undermining community safety.
“This reality calls on all of us to act,” said the mayor of Mont-Ngafula. “It requires collective awareness, but above all, concrete and lasting action.”
This is precisely the purpose of the forum: to bring together young people, health professionals, local authorities and the police to discuss effective ways of steering young people away from drugs and preventing urban violence.
“We need responsible young people who are engaged and aware of their rights, but also of their duties towards their community and their nation,” Séverin Lumbu stressed.
To combat drug use, he called for substantial efforts in education and prevention.
A shared commitment to fighting drug use
The police share this view.
The Deputy Executive Secretary of the Committee for Monitoring Police Reform in the Democratic Republic of the Congo, which co-organized the forum, also highlighted the harmful effects of hard liquor and drug use among young people.
“Drug addiction is a real scourge that destroys human lives in our society,” said Deputy Divisional Commissioner Jean-Rémy Nkanga, calling for coordinated action by all stakeholders in the sector.
His appeal echoed UNPOL’s advocacy. Edmond Tapsoba, who spoke on behalf of the MONUSCO Police at the forum, reminded participants that “security is a shared responsibility,” emphasizing the important role young people play in ensuring security in a vast municipality such as Mont-Ngafula.
There is indeed a link between the use of psychoactive substances and security.
Dr. Patrice Milambo, coordinator of the National Programme for Combating Drug Addiction and Toxic Substances, explained that, according to African Union figures, 6% of people who commit acts of violence do so under the influence of these substances. He described the connection as “clear.”
For Amisi of U-Report, the same pattern is evident. The more idle young people are, the more likely they are to turn to drugs, increasing the risk of their involvement in criminal activities.
He recalled a campaign he conducted in 2024 after noticing an increase in burglaries in his municipality on evenings when Africa Cup of Nations matches were being played.
The campaign revealed that many young people involved in the burglaries were using psychoactive substances.
Like all the other forum participants, Andréa Amisi is calling for greater awareness-raising and educational efforts among young people to address drug addiction.
U-Report is a community-based youth engagement platform that enables young people to express their views on issues that affect them.
In Mont-Ngafula, the platform reports having approximately 200 active young members, with just over 5,000 others following and participating in its activities across the municipality.
Distributed by APO Group on behalf of Mission de l'Organisation des Nations unies en République démocratique du Congo (MONUSCO).
Oct 23 · 09:31·APO Group
Finance · Healthcare
FLORHAM PARK, N.J., Oct. 23, 2026 — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on commercializing and developing novel treatments for gastrointestinal (GI) diseases, announced today that BDR Pharmaceuticals International Pvt. Ltd. (BDR) has filed suit against the U.S. Food and Drug Administration (FDA) and related Federal Defendants in the United … Continue reading "Phathom Pharmaceuticals Provides Update on Litigation Filed by BDR Pharmaceuticals against FDA"
Oct 23 · 08:15·PressReach